[Treatment results with dioxopromethazine nose drops].
D002986:Clinical Trials as Topic; D004155:Diphenhydramine / Q000627:therapeutic use*; D006651:Histocytochemistry; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D009278:Naphazoline / Q000627:therapeutic use; D009281:Naphthalenes / Q000627:therapeutic use*; D014663:Nasal Decongestants / Q000627:therapeutic use*; D009297:Nasal Mucosa / Q000187:drug effects / Q000473:pathology; D011398:Promethazine / Q000627:therapeutic use*; D012220:Rhinitis / Q000188:drug therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
D007093:Imidazoles; D009281:Naphthalenes; D014663:Nasal Decongestants; D004155:Diphenhydramine; D011398:Promethazine; D009278:Naphazoline
Behandlungsergebnisse mit Dioxopromethazin-Nasentropfen.